Table 1.
No. | Reference | Year | Sex | Age at diagnosis (years) | Crohn’s disease duration | IFX duration | Dose of IFX | Concomitant drug(s) | Medication | Clinical course |
---|---|---|---|---|---|---|---|---|---|---|
1 | Seddik et al. [6] | 2004 | Male | 29 | ND | 1 month | 5 mg/kg | PSL + AZA | ST | 2 weeks alive |
2 | Velayos et al. [7] | 2004 | Male | 19 | 2 years | 2 years 3 months | 5 mg/kg | AZA | ST + PSL | 2 weeks alive |
3 | Kaur et al. [8] | 2004 | Male | 59 | 3 weeks | 9 weeks | ND | PSL | ST + PM | 1 month died |
4 | Stratakos et al. [9] | 2005 | Female | 77 | 9 months | 8 months | 5 mg/kg | mPSL + AZA | ST | 6 month alive |
5 | Itaba et al. [10] | 2007 | Female | 57 | 21 years | 5 weeks | 5 mg/kg | PSL + AZA | ST + mPSL | 4 month alive |
6 | 金井 et al. [11] | 2009 | Male | 69 | 44 years | 4 weeks | 5 mg/kg | 5-ASA + PSL | ST + mPSL | 6 month alive |
7 | Tshudy et al. [12] | 2010 | Male | 8 | 6 years | 15 months | 5 mg/kg | None | ST | 4 weeks alive |
8 | Present case | 2014 | Male | 51 | 24 years | 10 years | 10 mg/kg | 6-MP (0.15 g/day) | ST | 1 year 5 month alive |
ST sulfamethoxazole/trimethoprim, PSL prednisolone, mPSL methylprednisolone, PM pentamidine, AZA azathioprine, 5-ASA mesalazine, 6-MP 6mercaptopurine, ND not described